Family members of idiopathic pulmonary fibrosis (IPF) patients across generations — their children and grandchildren — recently came together in London recently to sing an emotional rendition of Rachel Platten’s hit “Fight Song,” part of a global campaign (#fightsongchallenge) to promote disease awareness. The campaign encourages IPF patients and their…
‘Fight Song’ Unites Families of IPF Patients in Campaign of Awareness and Understanding
6 Pulmonary Fibrosis Risk Factors
Although pulmonary fibrosis (PF) can strike without any known cause (known as idiopathic pulmonary fibrosis) there are factors that can increase your risk of contracting the chronic lung disease. We’ve compiled a list of six risk factors for pulmonary fibrosis based on information from the Mayo Clinic. Age Typically…
When you are dealing with a disease or illness, your immune system is compromised, making it easier to pick up germs and bugs. While it’s impossible to live in a completely sterile environment, there are ways to try and minimize the amount of germs around your home according to the…
iBio, a developer of plant-based biotechnology, has announced the completion of expanded product development capacity at its subsidiary, iBio CMO, jointly owned with affiliates of Eastern Capital, for the production of pharmaceutical proteins in hydroponically-grown green plants and the large-scale manufacture of biological pharmaceutical products. iBio is…
Why We Can’t Stop Raising Awareness of IPF
Most people still don’t know what idiopathic pulmonary fibrosis (IPF) is. Unfortunately, raising awareness for a disease is an ongoing process. It’s essential we keep talking about it. Here are some simple facts about idiopathic pulmonary fibrosis. In this Irish…
I’ve been going to pulmonary rehab for about two years. It takes place at a very different kind of gym. It is a pulmonary rehab gym for people who have lung conditions and who need to be monitored (oxygen levels and heart rate) while exercising.
This video from the Lung Institute, shared in June 2015, is all about how yoga may help people with chronic lung diseases such as pulmonary fibrosis or COPD breathe easier. Staying healthy when you have pulmonary fibrosis. Find out more. Yoga is a gentle exercise that focuses on…
Bristol-Myers Squibb has acquired exclusive worldwide rights to Nitto Denko’s antifibrotic drug development efforts with siRNA molecules. In addition to the Japanese company’s lead compound ND-L02-s0201, currently in a Phase 1b clinical trial (NCT02227459) for advanced liver fibrosis, the agreement gives Bristol-Myers the right to obtain licenses for other…
PFF Summit: Managing Pulmonary Fibrosis Symptoms
In this video shared by the Pulmonary Fibrosis Foundation, we see a webinar filmed at the PFF Summit: From Bench to Bedside held in Washington D.C. in November 2015. Find out more about some of the early signs of pulmonary fibrosis here. Dr. Maryl E. Kreider presents…
Australian and German companies, AdAlta and XL-protein, have entered into a collaboration to create a long-acting form of AdAlta’s AD-114, an antibody-based treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic conditions. According to the agreement, XL-protein will contribute with their PASylation technology, attaching a string of amino acids that…
Your PF Community
Recent Posts
- How the PFF’s 5-year plan seeks to expand access to expert care January 27, 2026
- Inhaled IPF therapy LTI-03 awarded orphan drug status in Europe January 21, 2026
- Artificial intelligence has a role in medicine, and in my PF care January 20, 2026
- Starting the year with a vision of wellness and a plan to follow through January 15, 2026
- New trial data show oral therapy alters immune pathways in adults with IPF January 14, 2026
